Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex.
Schultz KAP, MacFarland SP, Perrino MR, Mitchell SG, Kamihara J, Nelson AT, Mallinger PHR, Brzezinski JJ, Maxwell KN, Woodward ER, Gallinger B, Kim SY, Greer MC, Schneider KW, Scollon SR, Das A, Wasserman JD, Eng C, Malkin D, Foulkes WD, Michaeli O, Bauer AJ, Stewart DR. Schultz KAP, et al. Among authors: maxwell kn. Clin Cancer Res. 2024 Nov 14. doi: 10.1158/1078-0432.CCR-24-1947. Online ahead of print. Clin Cancer Res. 2024. PMID: 39540884
Oncogenic Alterations, Race, and Survival in US Veterans with Metastatic Prostate Cancer Undergoing Somatic Tumor Next Generation Sequencing.
Valle LF, Li J, Desai H, Hausler R, Haroldsen C, Chatwal M, Ojo M, Kelley MJ, Rebbeck T, Rose BS, Rettig MB, Nickols NG, Garraway IP, Yamoah K, Maxwell KN. Valle LF, et al. Among authors: maxwell kn. bioRxiv [Preprint]. 2024 Oct 25:2024.10.24.620071. doi: 10.1101/2024.10.24.620071. bioRxiv. 2024. PMID: 39484518 Free PMC article. Preprint.
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. Leader AE, et al. Among authors: maxwell kn. BMC Public Health. 2024 Sep 18;24(1):2533. doi: 10.1186/s12889-024-20008-8. BMC Public Health. 2024. PMID: 39289635 Free PMC article.
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.
Safonov A, Marra A, Bandlamudi C, O'Leary B, Wubbenhorst B, Ferraro E, Moiso E, Lee M, An J, Donoghue MTA, Will M, Pareja F, Nizialek E, Lukashchuk N, Sofianopoulou E, Liu Y, Huang X, Ahmed M, Mehine MM, Ross D, Mandelker D, Ladanyi M, Schultz N, Berger MF, Scaltriti M, Reis-Filho JS, Li BT, Offit K, Norton L, Shen R, Shah S, Maxwell KN, Couch F, Domchek SM, Solit DB, Nathanson KL, Robson ME, Turner NC, Chandarlapaty S, Razavi P. Safonov A, et al. Among authors: maxwell kn. bioRxiv [Preprint]. 2024 Aug 26:2024.02.05.578934. doi: 10.1101/2024.02.05.578934. bioRxiv. 2024. PMID: 39253462 Free PMC article. Preprint.
Insights on Future Directions in Cancer Research from the AACR NextGen Stars.
Cañadas I, Casirati G, Houlahan KE, Maxwell KN, Mehta A, Parolia A, Saulnier O, Taylor AM, Thomas CE, Vázquez-García I. Cañadas I, et al. Among authors: maxwell kn. Cancer Discov. 2024 Sep 4;14(9):1584-1589. doi: 10.1158/2159-8290.CD-24-0774. Cancer Discov. 2024. PMID: 39228299 No abstract available.
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies.
Perrino MR, Das A, Scollon SR, Mitchell SG, Greer MC, Yohe ME, Hansford JR, Kalish JM, Schultz KAP, MacFarland SP, Kohlmann WK, Lupo PJ, Maxwell KN, Pfister SM, Weksberg R, Michaeli O, Jongmans MCJ, Tomlinson GE, Brzezinski J, Tabori U, Ney GM, Gripp KW, Gross AM, Widemann BC, Stewart DR, Woodward ER, Kratz CP. Perrino MR, et al. Among authors: maxwell kn. Clin Cancer Res. 2024 Nov 1;30(21):4834-4843. doi: 10.1158/1078-0432.CCR-24-1611. Clin Cancer Res. 2024. PMID: 39196581 Review.
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.
Leuva H, Zhou M, Jamaleddine N, Meseha M, Faiena I, Anna Park YH, McWilliams G, Luhrs C, Maxwell KN, Von Hoff D, Bates SE, Fojo T. Leuva H, et al. Among authors: maxwell kn. EBioMedicine. 2024 Sep;107:105288. doi: 10.1016/j.ebiom.2024.105288. Epub 2024 Aug 23. EBioMedicine. 2024. PMID: 39180789 Free PMC article.
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.
Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, Giri VN, Hall MJ, King MC, Lin DW, Loeb S, Morgan TM, Offit K, Pritchard CC, Schaeffer EM, Szymaniak BM, Vassy JL, Katona BW, Maxwell KN. Cheng HH, et al. Among authors: maxwell kn. JAMA Oncol. 2024 Sep 1;10(9):1272-1281. doi: 10.1001/jamaoncol.2024.2185. JAMA Oncol. 2024. PMID: 39052257 Review.
106 results